We are live on ! Find out more
MDVL

MedAvail Holdings, Inc. Common Stock

Delisted

MDVL was delisted on the 12th of February, 2024.

13 hedge funds and large institutions have $735K invested in MedAvail Holdings, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

30% more funds holding

Funds holding: 1013 (+3)

7% less capital invested

Capital invested by funds: $787K → $735K (-$51.6K)

Holders
13
Holders Change
+3
Holders Change %
+30%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

MDVL Hedge Fund Activity: Q4 2019 in Review

13 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in MedAvail Holdings, Inc. Common Stock (MDVL) for Q4 2019, worth a combined $735K — down 6.6% from $787K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new MDVL positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $51.9K. The largest seller was Morgan Stanley, cutting an estimated $5.11K.

  • 13 institutional investors held MedAvail Holdings, Inc. Common Stock (MDVL) as of Q4 2019, up from 10 in Q3 2019.
  • Funds reported $735K of MedAvail Holdings, Inc. Common Stock stock for Q4 2019, down 6.6% quarter-over-quarter.
  • 3 funds opened new MedAvail Holdings, Inc. Common Stock positions in Q4 2019 and 0 closed out, a net change of +3 holders.
  • The largest MedAvail Holdings, Inc. Common Stock buyer in Q4 2019 was Citadel Advisors, an estimated $51.9K added.
  • The largest MedAvail Holdings, Inc. Common Stock seller in Q4 2019 was Morgan Stanley, an estimated $5.11K sold.

Based on aggregated 13F filings for Q4 2019.